Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04939532 · ClinicalTrials.gov registry record · NA
SCALE-UP Utah: Community-Academic Partnership to Address COVID-19 Testing Among Utah Community Health Centers
A NA study, sponsored by University of Utah.
- Completed
- Registry status
- NA
- Development phase
- 44,729
- Enrollment target
NCT04939532: Completed NA study, sponsored by University of Utah.
NCT04939532 is a NA study that has completed, run by University of Utah. The registered enrollment target is 44,729 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (3088% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04939532, a NA study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- NA
- Development phase
- 44,729 participants
- Enrollment target
Study Summary
SCALE-UP Utah is a community-academic partnership to address COVID-19 among Utah community health centers. The long-term objective of the project is to increase the reach, acceptance, uptake, and long-term sustainability of COVID-19 screening and testing among Utah's Community Health Center patient population. The study will compare two practical, feasible, scalable interventions to increase COVID-19 testing uptake in Utah Community Health Centers: 1. Text Messaging (TM): population health management (PHM) intervention that analyzes EHR data to automatically identify patients with high risk for either infection or severe disease, reaches and screens those patients, and addresses testing logistics using bi-directional text messaging. 2. Patient Navigation (PN): PHM intervention to increase testing uptake among eligible patients (identified via TM) using patient navigation (e.g., motivating patients, addressing logistics and barriers). The project will employ a rapid cycle research approach in which interventions are tested on a small scale, using short time frames (e.g., \<1 month) and cyclical evaluation cycles. This process involves implementing intervention messages with a small number of clinics or patients, evaluating the outcomes, and either adapting the intervention messages based on findings (and retesting) or disseminating effective approaches to additional clinics or patients. A critical feature of these cycles is the ability to quickly test and refine messages in a limited setting before broader implementation. Throughout the study, intervention messages were updated or adapted in response to evolving public health guidelines, testing procedures, and policy recommendations (e.g., priority populations by age group or geographic area, as advised by the Utah Department of Health and Human Services and relevant federal agencies). However, these updates did not alter the fundamental structure of the intervention arms. Participants were randomized to one of tw
Primary Outcome
Proportion of patients that respond to the Text Messaging intervention.
Interventions
- BEHAVIORAL Patient Navigation (PN)
- BEHAVIORAL Text-Messaging (TM)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44,729 participants |
| Start Date | 2021-03-29 |
| Est. Completion | 2023-02-28 |
| Phase | NA |
What the finished NCT04939532 record still lists
NCT04939532 is an interventional study that assigns participants to a tested intervention. Its 44,729 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (3088% higher).
The record links to 0 conditions, and to 2 interventions - of which Patient Navigation (PN) is the first listed.
NCT04939532 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04939532 about?
NCT04939532 is a clinical study titled "SCALE-UP Utah: Community-Academic Partnership to Address COVID-19 Testing Among Utah Community Health Centers". SCALE-UP Utah is a community-academic partnership to address COVID-19 among Utah community health centers. The long-term objective of the project is to increase the reach, acceptance, uptake, and long-term sustainability of COVID-19 screening and testing among Utah's Community Health Center patient ...
What is the current status of trial NCT04939532?
This trial is currently completed. It is a NA study. The enrollment target is 44,729 participants. The study started on 2021-03-29. Estimated completion is 2023-02-28.
What interventions are being tested in trial NCT04939532?
The interventions under investigation include: Patient Navigation (PN) (BEHAVIORAL), Text-Messaging (TM) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04939532?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04939532's enrollment target sits among peer trials
44,729 7th of 2000 higher than 1,994 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05607732 · 45,257 participants · NA
Primary Care Detection of Cognitive Impairment Leveraging Health & Consumer Technologies in Underserved Communities: The MyCog Trial
- NCT06824350 · 45,450 participants · NA
Clean Trial - Chlorination to Reduce Enteric and Antibiotic Resistant Infections in Neonates
- NCT06597968 · 45,991 participants
Evaluating the Real World Performance of an AI Based Lung Nodule Detection Tool
- NCT03977402 · 47,500 participants
Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI